Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1326 ARTÍCULOS , VIENDO DEL 1246 AL 1260

Beyond diagnosis: what biomarkers are teaching us about the "bio"logy of Alzheimer disease

Rabinovici GD, Roberson ED.

Ann Neurol. 2010 Mar;67(3):283-5. doi: 10.1002/ana.22020.

Biomarkers of oxidative damage and inflammation in Alzheimer's disease

Galasko D, Montine TJ.

Biomark Med. 2010 Feb;4(1):27-36. doi: 10.2217/bmm.09.89.

Alzheimer's prevention initiative: a proposal to evaluate presymptomatic treatments as quickly as possible

Reiman EM, Langbaum JB, Tariot PN.

Biomark Med. 2010 Feb;4(1):3-14. doi: 10.2217/bmm.09.91.

Biomarkers in Alzheimer's disease: past, present and future

Gustaw-Rothenberg K, Lerner A, Bonda DJ, Lee HG, Zhu X, Perry G, Smith MA.

Biomark Med. 2010 Feb;4(1):15-26. doi: 10.2217/bmm.09.86.

Role of progranulin as a biomarker for Alzheimer's disease

Sleegers K, Brouwers N, Van Broeckhoven C.

Biomark Med. 2010 Feb;4(1):37-50. doi: 10.2217/bmm.09.82.

Blood-based biomarkers of Alzheimer's disease: challenging but feasible

Thambisetty M, Lovestone S.

Biomark Med. 2010 Feb;4(1):65-79. doi: 10.2217/bmm.09.84.

Role of biochemical Alzheimer's disease biomarkers as end points in clinical trials

Siemers E, DeMattos RB, May PC, Dean RA.

Biomark Med. 2010 Feb;4(1):81-9. doi: 10.2217/bmm.09.85.

Biochemical markers in Alzheimer's disease clinical trials

Zetterberg H, Mattsson N, Shaw LM, Blennow K.

Biomark Med. 2010 Feb;4(1):91-8. doi: 10.2217/bmm.09.80.

Correlating familial Alzheimer's disease gene mutations with clinical phenotype

Ryan NS, Rossor MN.

Biomark Med. 2010 Feb;4(1):99-112. doi: 10.2217/bmm.09.92.

Biomarkers in translational research of Alzheimer's disease

Tarawneh R, Holtzman DM.

Neuropharmacology. 2010 Sep-Oct;59(4-5):310-22. doi: 10.1016/j.neuropharm.2010.04.006. Epub 2010 Apr 13.

Cerebrospinal fluid proteins in the diagnosis of Alzheimer's disease

Papaliagkas VT, Tsolaki M, Anogianakis G.

Recent Pat CNS Drug Discov. 2010 Jun;5(2):172-8. doi: 10.2174/157488910791213194.

Biomarkers as predictors for conversion from mild cognitive impairment to Alzheimer-type dementia: implications for trial design

van Rossum IA, Vos S, Handels R, Visser PJ.

J Alzheimers Dis. 2010;20(3):881-91. doi: 10.3233/JAD-2010-091606.

Should olfactory dysfunction be used as a biomarker of Alzheimer's disease?

Wesson DW, Wilson DA, Nixon RA.

Expert Rev Neurother. 2010 May;10(5):633-5. doi: 10.1586/ern.10.33.

A novel MRI-biomarker candidate for Alzheimer's disease composed of regional brain volume and perfusion variables

Luckhaus C, Jänner M, Cohnen M, Flüss MO, Teipel SJ, Grothe M, Hampel H, Kornhuber J, Rüther E, Peters O, Supprian T, Gaebel W, Mödder U, Wittsack HJ.

Eur J Neurol. 2010 Dec;17(12):1437-44. doi: 10.1111/j.1468-1331.2010.03038.x.

Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease

Frisardi V, Solfrizzi V, Seripa D, Capurso C, Santamato A, Sancarlo D, Vendemiale G, Pilotto A, Panza F.

Ageing Res Rev. 2010 Oct;9(4):399-417. doi: 10.1016/j.arr.2010.04.007. Epub 2010 May 2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias